SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells

NCT00091130 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

139

Enrollment

NIH

Sponsor class

Conditions

Atypical Squamous Cells of Undetermined Significance
Cervical Cancer
High-grade Squamous Intraepithelial Lesion
Low-grade Squamous Intraepithelial Lesion

Interventions

BIOLOGICAL: HspE7
OTHER: placebo
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)